Bahendeka, Silver
Wesonga, Ronald
Were, Thereza Piloya
Nyangabyaki, Catherine
Funding for this research was provided by:
Autoantibodies and HLA Class II DR-DQ genotypes in Ugandan Children and Adolescents with Type 1 Diabetes Mellitus
Africa Field Epidemiology Network (None)
Article History
Received: 18 August 2017
Accepted: 5 March 2018
First Online: 26 March 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: Informed consent was obtained from all individual participants included in the study: children aged 8–17 years assented to participate, with parents of children below age of 18 years giving the informed consent. Participants above the age of 18 years were eligible and gave informed consent to participate.
: Ethical approval was obtained from St. Francis Hospital, Nsambya and Mulago Hospital Institutional Review Boards/Review Ethical Committees; both of which are accredited by the Uganda National Council of Science and Technology (UNCST). All procedures performed in this study were in accordance with the ethical standards of UNCST and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.